Darolutamide

Trade Name: 
Nubeqa
Manufacturer/Distributor: 
Bayer Inc.
Classification: 
Anti-androgen
ATC Class: 
L02BB06 - darolutamide
Status: 
active
Notice of Compliance (yyyy/mm/dd): 
2020/02/19
Date Marketed in Canada (yyyy/mm/dd): 
2020/03/24
Presentation: 
Tablet: 300 mg. DIN: 02496348
Comments: 
Used for the treatment of patients with non-metastatic castration resistant prostate cancer.